This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wilson WA et al. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42: 1309–1311
Finazzi G et al. (1996) Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med 100: 530–536
Shah NM et al. (1998) Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus 7: 3–6
Girón-González JA et al. (2004) Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 31: 1560–1567
National Heart, Lung and Blood Institute. The Framingham Heart Study [http://www.framingham.com/heart/]
Acknowledgements
The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
O'Neil, K. Should aspirin be used as a preventive therapy for thrombosis in patients with antiphospholipid antibodies?. Nat Rev Rheumatol 4, 14–15 (2008). https://doi.org/10.1038/ncprheum0682
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0682